Switch to dolutegravir is well tolerated in Thais with HIV infection

• Main Authors: Goh, O.Q., Colby, D.J., Pinyakorn, S., Sacdalan, C., Kroon, E., Chan, P., Chomchey, N., Kanaprach, R., Prueksakaew, P., Suttichom, D., Trichavaroj, R., Spudich, S., Robb, M.L., Phanuphak, P., Phanuphak, N., Ananworanich, J., on behalf of RV254/SEARCH 010 Study Group.
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: John Wiley and Sons Inc. 2022
• Subjects: adverse effects; Asian; dolutegravir; hepatitis C; HIV; toxicity
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/212958
• Institution: National University of Singapore

10.1002/jia2.25324